Basel Medical BMGL
NASDAQ BMGL
$4.68 -0.26 (-5.26%)
At close: Sep 3, 2026 · 4:00 PM EDT

Basel Medical (BMGL) Income towards Parent Company (2023 - 2024)

Basel Medical (BMGL) posted Income towards Parent Company of $160458.0 for Q4 2025.

Analysis

Basel Medical (BMGL) Income towards Parent Company (2023 - 2024) Analysis & Trends

Basel Medical has reported Income towards Parent Company for 1 years, with the latest figure at $160458.0 in Q4 2025.

  • Quarterly Income towards Parent Company changed N/A year-over-year to $160458.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $160458.0 (changed N/A YoY) and the FY2025 annual result came in at -$8.4 million, down 645.8% from the prior year.
  • Income towards Parent Company held at $160458.0 in Q4 2025 per BMGL's latest filing.
  • Over five years, Income towards Parent Company peaked at $160458.0 in Q4 2025 and troughed at $160458.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 89.08 Bn 88.07 Bn 15.19 Bn
2 Tenet Healthcare 22.05 Bn 19.88 Bn 4.45 Bn
3 Encompass Health 12.07 Bn 11.94 Bn 1.34 Bn
4 Davita 11.84 Bn 11.16 Bn 1.16 Bn
5 Universal Health Services 10.13 Bn 9.99 Bn 3.29 Bn
6 Ensign 9.93 Bn 9.61 Bn 306.24 Mn
7 Chemed 6.85 Bn 6.81 Bn 221.47 Mn
8 Pacs 6.76 Bn 6.59 Bn 338.46 Mn
9 Concentra Group Holdings Parent 4.30 Bn 4.15 Bn 192.10 Mn
10 Basel Medical 7.33 Mn 6.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 317,031.00
Dec 31, 2023 2.55 Mn